Aveed 750 MG/3 ML vial 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV510
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,369
Award facts
- Contract value 100% obligated
- $24,368.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 13, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $24,368.64 to AmerisourceBergen Drug Corp for AVEED 750 MG/3 ML Vial 3ML, a testosterone replacement therapy medication. This firm fixed-price delivery order, with an ultimate completion date of February 4, 2026, was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of parent company Cencora, Inc. (formerly AmerisourceBergen), a major pharmaceutical distributor serving federal healthcare agencies including the Department of Defense and Defense Health Agency.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 prime vendor agreement valued through December 2026 that enables the contractor to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The IDC serves military treatment facilities, veterans' healthcare systems, and other federal medical institutions, covering specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. AmerisourceBergen's consistent award of delivery orders demonstrates its capability to meet federal procurement requirements for essential pharmaceutical commodities supporting the military healthcare supply chain.
Quick answers
Who was awarded contract SPE2DR26FV510?
SPE2DR26FV510 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FV510 worth?
The government has obligated $24,369 on SPE2DR26FV510.
Is contract SPE2DR26FV510 an order under another contract?
Yes. SPE2DR26FV510 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV510 competed?
The extent of competition for SPE2DR26FV510 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award